Compare Teucrium Soybean Fund (SOYB) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teucrium Soybean Fund vs UnitedHealth Group Inc — how do they compare? Teucrium Soybean Fund trades at $27.66, while UnitedHealth Group Inc trades at $394.1 (market cap $359.79B). The key difference: UnitedHealth Group Inc pays a 2.32% dividend while Teucrium Soybean Fund pays none, and Teucrium Soybean Fund is trading nearer its 52-week high, UnitedHealth Group Inc nearer its low. Which is the better fit depends on your goals.
| SOYB | UNH | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $27.84 | $436.35 |
52-Week Low | $21.46 | $259.02 |
Market Cap | — | $359.79B |
Enterprise Value | — | $401.65B |
Dividend Yield | — | 2.32% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOYB trades at $27.84, up 0.69% today, with a bullish technical signal from moving averages but bearish oscillators. The stock shows strong momentum indicators, with RSI levels indicating overbought conditions. Recent news highlights commodity price trends influencing agricultural stocks.
The outlook remains tied to commodity market dynamics, with potential upside from rising soybean prices but risks from geopolitical tensions and volatility. Investors should weigh technical overbought signals against fundamental growth catalysts in the agricultural sector.
UnitedHealth Group (UNH) trades at $393.06, down 1.03% on the day, with a bullish technical signal from moving averages and strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
The outlook for UNH is positive, driven by aging demographics, Medicare growth, and operational efficiencies, though risks include regulatory scrutiny and margin pressures. With 82.7% of analysts rating it a buy and a consensus price target of $475.47, the stock presents a compelling opportunity for long-term investors seeking exposure to healthcare stability and dividend growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
